ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sobi launches thrombocytopenia drug Doptelet in EU pharmatimes
November 06, 2020Sobi (Swedish Orphan Biovitrum) has launched Doptelet (avatrombopag) in Europe, which is approved for the treatment of severe thrombocytopenia in adult patients with chronic liver disease (CLD).
Pharma Sources Insight January 2025
